DCM
DAFNA Capital Management Portfolio holdings
AUM
$405M
1-Year Est. Return
24.52%
1 Year Est. Return
+24.52%
AUM
$405M
AUM Growth
+$42.5M
(+12%)
Holding
83
Top Buys
| 1 | +$3.58M | |
| 2 | +$2.56M | |
| 3 | +$2.23M | |
| 4 |
Larimar Therapeutics
LRMR
|
+$2.12M |
| 5 |
Aquestive Therapeutics
AQST
|
+$2.07M |
Top Sells
| 1 | +$21.6M | |
| 2 | +$16.8M | |
| 3 | +$10.9M | |
| 4 |
Ascendis Pharma
ASND
|
+$7.85M |
| 5 |
Stoke Therapeutics
STOK
|
+$7.81M |
Sector Composition
| 1 | Healthcare | 85.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
76
DELISTED
Blueprint Medicines
BPMC
| – | – |
-168,763
|
|
||
77
Gossamer Bio
GOSS
$738M
| – | – |
-849,921
|
|
||
78
InflaRx
IFRX
$78.6M
| – | – |
-200,000
|
|
||
|
ITOS
79
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-140,847
|
|
||
80
Procept Biorobotics
PRCT
$1.72B
| – | – |
-3,000
|
|
||
81
VYNE Therapeutics
VYNE
$12.2M
| – | – |
-636,103
|
|
||
|
PVLA
82
Palvella Therapeutics
PVLA
$1.12B
| – | – |
-43,348
|
|